The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity (FLUOXETINE)
This study has been completed.
Sponsor:
University of Washington
Collaborator:
Information provided by (Responsible Party):
Justin Lutz, University of Washington
ClinicalTrials.gov Identifier:
NCT01361217
First received: May 16, 2011
Last updated: June 18, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2012 |
| Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |